{"prompt": "['Novartis', 'Confidential', 'Page 37', 'Amended Protocol Version 03 (Clean)', 'Protocol No. CQAW039A2322', 'Table 8-1', 'Assessment Schedule', 'Period', 'Screening', 'Treatment', 'EOT or', 'Visit Name', 'Screening', 'Run-in\u00b9', 'Treatment', 'TD', 'Follow-up', 'Days', '-42 to -28', '-28 to -1', '1', '1', '28', '56', '84', '112', '124', 'Weeks', '-6 to -4', '-4 to -1', '1', '1', '4', '8', '12', '16', '18', 'Informed consent', 'X', 'Inclusion / Exclusion criteria', 'X', 'X', 'X', 'Demography', 'X', 'Physical Examination', 'S', 'S', 'Medical history/current medical', 'X', 'conditions', 'Surgeries and Procedures', 'X', 'Prior medications', 'X', 'Safety Follow up Call', 'S', 'ACQ-5', 'X', 'Vital Signs', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Body Height', 'X', 'Electrocardiogram (ECG)', 'X', 'X', 'X', 'Body Weight', 'X', 'Pregnancy Test (serum)', 'X', 'Pregnancy Test (Urine)', 'S', 'S', 'S', 'S', 'S', 'Hematology', 'X', 'X', 'X', 'X', 'HbA1C', 'X', 'X', 'Clinical Chemistry', 'X', 'X', 'X', 'X', 'Urinalysis', 'X', 'X', 'Check IMP Compliance', 'S', 'S', 'S', 'S', 'Contact IRT (IVRS/IWRS)', 'S', 'S', 'S', 'S', 'S', 'S', 'S', 'S', 'Randomization', 'S']['Novartis', 'Confidential', 'Page 38', 'Amended Protocol Version 03 (Clean)', 'Protocol No. CQAW039A2322', 'Period', 'Screening', 'Treatment', 'EOT or', 'Visit Name', 'Screening', 'Run-in\u00b9', 'Treatment', 'TD', 'Follow-up', 'Days', '-42 to -28', '-28 to -1', '1', '1', '28', '56', '84', '112', '124', 'Weeks', '-6 to -4', '-4 to -1', '1', '1', '4', '8', '12', '16', '18', 'Study Drug Dispensation', 'S', 'S', 'S', 'S', 'Study drug administration', 'Daily', 'SoC/Rescue Medication Dispense', 'S', 'S', 'S', 'S', 'S', 'S', 'Adverse Events', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Serious Adverse Events', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Concomitant medications', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Liver Event Monitoring2', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Renal Event Monitoring3', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Nasal Endoscopy4', 'X', 'X', 'X', 'X', 'Nasal Congestion Score', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Questionnaire', 'QoL Questionnaire (SNOT-22)', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Smell Assessment (UPSIT)', 'X', 'X', 'X', 'X', 'X', 'Study completion information', 'X Assessment to be recorded in the clinical database or received electronically from a vendor', 'S Assessment to be recorded in the source documentation only', '1 Assessments at Run-in Day 1 will be performed prior to Randomization. Run-in Day 1 and the Treatment Day 1 visit will take place on the same day if the patient is', 'randomized', '2 Please refer to protocol Section 10.2.1', '3 Please refer to protocol Section 10.2.2', '4', 'Nasal polyp score will be determined by central reading.', '5', '6 For patient familiarization with device only.']\n\n###\n\n", "completion": "END"}